Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by mdjbrownon Apr 06, 2024 12:10pm
87 Views
Post# 35974825

RE:RE:Our competition and somewhat good news. MEDIF update us pls.

RE:RE:Our competition and somewhat good news. MEDIF update us pls.QC, I am not so sure some of these medical cannabis will be held up as long as traditional FDA medicine approvals, due to its infancy in medicine.

Look no further than Epidiolex, which at the time using cannaboids for medicinal applications was a red herring, yet it was approved much quicker than a lot of drugs in the pipeline.

https://panacealife.com/the-history-of-epidiolex/


I get the impression CBD medicines will become more mainstream and as a result fast tracked by the FDA and other regulatory agents if they can prove CBD formulations beneficial in opioid trials as the global epidemic is completely out of control.

Big if, but not out of the realm of possibility.
<< Previous
Bullboard Posts
Next >>